Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $594.7250 (-1.32%) ($594.7250 - $594.7250) on Tue. Jun. 28, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.04% (three month average) | RSI | 43 | Latest Price | $594.7250(-1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | Weekly Trend | REGN advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) DIA(38%) IWD(35%) SPLV(34%) SPY(34%) | Factors Impacting REGN price | REGN will decline at least -1.02% in a week (0% probabilities). VIXM(-10%) TBT(-9%) UUP(-6%) EDOC(-4%) VXX(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.02% (StdDev 2.04%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Resistance Level | $596.61 | 5 Day Moving Average | $600.91(-1.03%) | 10 Day Moving Average | $585.12(1.64%) | 20 Day Moving Average | $596.61(-0.32%) | To recent high | -19.5% | To recent low | 8.6% | Market Cap | $63.058b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |